These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26512890)

  • 1. Deficient and Null Variants of SERPINA1 Are Proteotoxic in a Caenorhabditis elegans Model of α1-Antitrypsin Deficiency.
    Cummings EE; O'Reilly LP; King DE; Silverman RM; Miedel MT; Luke CJ; Perlmutter DH; Silverman GA; Pak SC
    PLoS One; 2015; 10(10):e0141542. PubMed ID: 26512890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A C. elegans model of human α1-antitrypsin deficiency links components of the RNAi pathway to misfolded protein turnover.
    Long OS; Benson JA; Kwak JH; Luke CJ; Gosai SJ; O'Reilly LP; Wang Y; Li J; Vetica AC; Miedel MT; Stolz DB; Watkins SC; Züchner S; Perlmutter DH; Silverman GA; Pak SC
    Hum Mol Genet; 2014 Oct; 23(19):5109-22. PubMed ID: 24838286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluphenazine reduces proteotoxicity in C. elegans and mammalian models of alpha-1-antitrypsin deficiency.
    Li J; Pak SC; O'Reilly LP; Benson JA; Wang Y; Hidvegi T; Hale P; Dippold C; Ewing M; Silverman GA; Perlmutter DH
    PLoS One; 2014; 9(1):e87260. PubMed ID: 24498058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHOP and c-JUN up-regulate the mutant Z α
    Attanasio S; Ferriero R; Gernoux G; De Cegli R; Carissimo A; Nusco E; Campione S; Teckman J; Mueller C; Piccolo P; Brunetti-Pierri N
    J Biol Chem; 2020 Sep; 295(38):13213-13223. PubMed ID: 32723872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The aggregation-prone intracellular serpin SRP-2 fails to transit the ER in Caenorhabditis elegans.
    Silverman RM; Cummings EE; O'Reilly LP; Miedel MT; Silverman GA; Luke CJ; Perlmutter DH; Pak SC
    Genetics; 2015 May; 200(1):207-19. PubMed ID: 25786854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency.
    Callea F; Giovannoni I; Francalanci P; Boldrini R; Faa G; Medicina D; Nobili V; Desmet VJ; Ishak K; Seyama K; Bellacchio E
    Orphanet J Rare Dis; 2018 May; 13(1):79. PubMed ID: 29769092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New
    Matamala N; Gomez-Mariano G; Perez JA; Baladrón B; Torres-Durán M; Michel FJ; Saez R; Hernández-Pérez JM; Belmonte I; Rodriguez-Frias F; Blanco I; Strnad P; Janciauskiene S; Martinez-Delgado B
    Am J Respir Cell Mol Biol; 2020 Oct; 63(4):444-451. PubMed ID: 32515985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple Genes Core to ERAD, Macroautophagy and Lysosomal Degradation Pathways Participate in the Proteostasis Response in α1-Antitrypsin Deficiency.
    Li J; Moretti F; Hidvegi T; Sviben S; Fitzpatrick JAJ; Sundaramoorthi H; Pak SC; Silverman GA; Knapp B; Filipuzzi I; Alford J; Reece-Hoyes J; Nigsch F; Murphy LO; Nyfeler B; Perlmutter DH
    Cell Mol Gastroenterol Hepatol; 2024; 17(6):1007-1024. PubMed ID: 38336172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha 1-antitrypsin-deficient variant Siiyama (Ser53[TCC] to Phe53[TTC]) is prevalent in Japan. Status of alpha 1-antitrypsin deficiency in Japan.
    Seyama K; Nukiwa T; Souma S; Shimizu K; Kira S
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2119-26. PubMed ID: 8520784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-1-antitrypsin (SERPINA1) mutation spectrum: Three novel variants and haplotype characterization of rare deficiency alleles identified in Portugal.
    Silva D; Oliveira MJ; Guimarães M; Lima R; Gomes S; Seixas S
    Respir Med; 2016 Jul; 116():8-18. PubMed ID: 27296815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analog of glibenclamide selectively enhances autophagic degradation of misfolded α1-antitrypsin Z.
    Wang Y; Cobanoglu MC; Li J; Hidvegi T; Hale P; Ewing M; Chu AS; Gong Z; Muzumdar R; Pak SC; Silverman GA; Bahar I; Perlmutter DH
    PLoS One; 2019; 14(1):e0209748. PubMed ID: 30673724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of PGC1α Downstream of the Insulin Signaling Pathway Plays a Role in the Hepatic Proteotoxicity of Mutant α1-Antitrypsin Deficiency Variant Z.
    Rudnick DA; Huang J; Hidvegi T; Chu AS; Hale P; Munanairi A; Dietzen DJ; Cliften PF; Tycksen E; Lutkewitte AJ; Finck BN; Pak SC; Silverman GA; Perlmutter DH
    Gastroenterology; 2022 Jul; 163(1):270-284. PubMed ID: 35301011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants of alpha1-antitrypsin.
    Salahuddin P
    Curr Protein Pept Sci; 2010 Mar; 11(2):101-17. PubMed ID: 19751191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-1 Antitrypsin Genotype-Phenotype Discrepancy in a 42-Year-Old Man Who Carries the Null-Allele.
    Pavičić T; Ćelap I; Njegovan M; Tešija Kuna A; Štefanović M
    Lab Med; 2020 May; 51(3):301-305. PubMed ID: 31583408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three new alpha1-antitrypsin deficiency variants help to define a C-terminal region regulating conformational change and polymerization.
    Fra AM; Gooptu B; Ferrarotti I; Miranda E; Scabini R; Ronzoni R; Benini F; Corda L; Medicina D; Luisetti M; Schiaffonati L
    PLoS One; 2012; 7(6):e38405. PubMed ID: 22723858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting intracellular degradation pathways for treatment of liver disease caused by α1-antitrypsin deficiency.
    Wang Y; Perlmutter DH
    Pediatr Res; 2014 Jan; 75(1-2):133-9. PubMed ID: 24226634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical heterogeneity and potential high pathogenicity of the Mmalton Alpha 1 antitrypsin allele at the homozygous, compound heterozygous and heterozygous states.
    Joly P; Guillaud O; Hervieu V; Francina A; Mornex JF; Chapuis-Cellier C
    Orphanet J Rare Dis; 2015 Oct; 10():130. PubMed ID: 26446624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel alpha1-antitrypsin null variant (Q0Cairo).
    Zorzetto M; Ferrarotti I; Campo I; Balestrino A; Nava S; Gorrini M; Scabini R; Mazzola P; Luisetti M
    Diagn Mol Pathol; 2005 Jun; 14(2):121-4. PubMed ID: 15905697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alpha-1 antitrypsin deficiency caused by Null mutation].
    Perrin J; Aimone-Gastin I; Balduyck M; Mercy M; Filhine-Trésarrieu P; Odou MF; Chaouat A; Chabot F
    Rev Mal Respir; 2016 Sep; 33(7):612-7. PubMed ID: 26604020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cells model personalized variations in liver disease resulting from α1-antitrypsin deficiency.
    Tafaleng EN; Chakraborty S; Han B; Hale P; Wu W; Soto-Gutierrez A; Feghali-Bostwick CA; Wilson AA; Kotton DN; Nagaya M; Strom SC; Roy-Chowdhury J; Stolz DB; Perlmutter DH; Fox IJ
    Hepatology; 2015 Jul; 62(1):147-57. PubMed ID: 25690322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.